Upstream Bio, Inc.
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | 2.3% | 8.0% | 7.6% | 6.1% | 4.5% | 8.5% | 4.7% | – | – | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 95.3% | 100.0% | 98.4% | |
| 1,254.1% | 2,567.6% | 1,826.7% | 2,758.6% | 2,542.5% | 3,551.9% | 4,557.8% | 4,041.1% | 4,828.0% | 6,013.3% | 3,536.3% | 4,668.7% | 4,616.8% | |
| 357.3% | 716.9% | 619.1% | 780.6% | 670.0% | 841.4% | 1,198.2% | 791.8% | 811.4% | 997.9% | 781.8% | 912.3% | 865.9% | |
| 1,611.4% | 3,284.4% | 2,445.8% | 3,539.2% | 3,212.5% | 4,393.3% | 5,756.0% | 4,832.9% | 5,639.4% | 7,011.2% | 4,313.3% | 5,581.0% | 5,481.1% | |
| -1,511.4% | -3,184.4% | -2,345.8% | -3,439.2% | -3,112.5% | -4,293.3% | -5,656.0% | -4,732.9% | -5,539.4% | -6,911.2% | -4,218.1% | -5,481.0% | -5,382.6% | |
| -499.5% | -2,629.6% | -1,702.2% | -2,878.0% | -2,634.6% | -3,465.3% | -4,818.0% | -4,265.3% | -4,941.1% | -6,356.1% | -3,925.6% | -5,136.1% | -4,955.7% | |
| -499.5% | -2,629.6% | -1,702.2% | -2,878.0% | -2,634.6% | -3,465.3% | -4,818.0% | -4,265.3% | -4,941.1% | -6,356.1% | -3,925.6% | -5,136.1% | -4,955.7% | |
| -496.8% | -2,626.4% | -1,700.2% | -2,875.5% | -2,632.3% | -3,457.3% | -4,810.4% | -4,260.8% | -4,934.4% | -6,347.6% | -3,920.9% | -5,136.1% | -4,950.9% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.